Annovis Bio, Inc. (ANVS)
0.9934
-0.06
(-5.39%)
USD |
NYSE |
Oct 16, 16:00
1.00
+0.01
(+0.66%)
Pre-Market: 20:00
Annovis Bio EPS Diluted (Quarterly) : -0.395 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.395 |
| March 31, 2026 | -0.6322 |
| December 31, 2025 | -0.3964 |
| September 30, 2025 | -0.3689 |
| June 30, 2025 | -0.3192 |
| March 31, 2025 | -0.3176 |
| December 31, 2024 | -0.4778 |
| September 30, 2024 | -0.974 |
| June 30, 2024 | -0.444 |
| March 31, 2024 | -0.1004 |
| December 31, 2023 | -2.332 |
| September 30, 2023 | -1.633 |
| June 30, 2023 | -1.065 |
| March 31, 2023 | -1.188 |
| December 31, 2022 | -0.3791 |
| September 30, 2022 | -0.7879 |
| June 30, 2022 | -0.7272 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.6416 |
| December 31, 2021 | -0.7302 |
| September 30, 2021 | -0.3517 |
| June 30, 2021 | -0.3427 |
| March 31, 2021 | -0.4623 |
| December 31, 2020 | -0.2474 |
| September 30, 2020 | -0.1464 |
| June 30, 2020 | -0.3366 |
| March 31, 2020 | -0.096 |
| December 31, 2019 | -0.0294 |
| September 30, 2019 | -0.0373 |
| June 30, 2019 | -0.0506 |
| March 31, 2019 | -0.028 |
| December 31, 2018 | -0.0246 |
| September 30, 2018 | -0.0202 |
| June 30, 2018 | -0.032 |
| March 31, 2018 | -0.0279 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.82M |
| Total Expenses (Quarterly) | 14.82M |
| Enterprise Value | 23.60M |
| Earnings Yield | -180.4% |
| Normalized Earnings Yield | -182.20 |